Drilldown: Medicines
Use the filters below to narrow your results.
generic:
None (3) ·
Alprazolam (1) ·
Asenapine (1) ·
Bromazepam (1) ·
Chlordiazepoxide (1) ·
Chlorpromazine (1) ·
Clobazam (1) ·
Clonazolam (1) ·
Clorazepate (1) ·
Diclazepam (1) ·
Droperidol (1) ·
Estazolam (1) ·
Flualprazolam (1) ·
Flubromazepam (1) ·
Flubromazolam (1) ·
Flunitrazepam (1) ·
Flunitrazolam (1) ·
Fluphenazine (1) ·
Flurazepam (1) ·
Iloperidone (1) ·
Lormetazepam (1) ·
Loxapine (1) ·
Lurasidone (1) ·
Midazolam (1) ·
Molindone (1) ·
Nifoxipam (1) ·
Nitrazepam (1) ·
Oxazepam (1) ·
Paliperidone (1) ·
Perphenazine (1) ·
Pimozide (1) ·
Pyrazolam (1) ·
Quazepam (1) ·
Temazepam (1) ·
Thioridazine (1) ·
Thiothixene (1) ·
Triazolam (1) ·
Trifluoperazine (1) ·
Ziprasidone (1)
brand:
None (9) ·
Ajovy (1) ·
Dalmane (1) ·
Doral (1) ·
Emgality (1) ·
Fanapt (1) ·
Geodon (1) ·
Halcion (1) ·
Inapsine (1) ·
Invega (1) ·
Latuda (1) ·
Lexotan (1) ·
Librium (1) ·
Loxitane (1) ·
Mellaril (1) ·
Moban (1) ·
Mogadon (1) ·
Navane (1) ·
Onfi (1) ·
Orap (1) ·
Prolixin (1) ·
ProSom (1) ·
Restoril (1) ·
Rohypnol (1) ·
Saphris (1) ·
Serax (1) ·
Stelazine (1) ·
Thorazine (1) ·
Tranxene (1) ·
Trilafon (1) ·
Versed (1) ·
Vyepti (1) ·
Xanax (1)
classes: (Click arrow to add another value)
mechanism:
Butyrophenone D2 antagonist (1) ·
D2 receptor antagonist; also H1, alpha-1, muscarinic antagonist (1) ·
D2/5-HT2A antagonist (1) ·
D2/5-HT2A antagonist; 5-HT7 antagonist (1) ·
D2/5-HT2A antagonist; active metabolite of risperidone (1) ·
D2/5-HT2A antagonist; SRI and NRI (1) ·
Dibenzoxazepine D2/5-HT2 antagonist (1) ·
Dihydroindolone D2 antagonist (1) ·
Diphenylbutylpiperidine D2 antagonist (1) ·
Extremely potent GABAA positive allosteric modulator (1) ·
GABA-A positive allosteric modulator'"`UNIQ--ref-00000067-QINU`"' '"`UNIQ--vote-00000068-QINU`"' (1) ·
GABAA positive allosteric modulator (18) ·
GABAA positive allosteric modulator; low sedation (1) ·
GABAA positive allosteric modulator; prodrug of desmethyldiazepam (1) ·
GABAA positive allosteric modulator; very long half-life (1) ·
Humanized IgG1 monoclonal antibody binding CGRP peptide; IV infusion enables fastest onset of any CGRP mAb (1) ·
Humanized IgG2 monoclonal antibody binding both isoforms of CGRP peptide (1) ·
Humanized IgG4 monoclonal antibody binding CGRP peptide; prevents CGRP from activating its receptor (1) ·
Multi-receptor antagonist (D2, 5-HT2A, H1, alpha) (1) ·
Phenothiazine D2 antagonist (4) ·
Thioxanthene D2 antagonist (1)
uses:
None (37) ·
Preventive treatment of migraine in adults (1) ·
Preventive treatment of migraine in adults (episodic and chronic) (1) ·
Preventive treatment of migraine in adults; episodic cluster headache (1) ·
'"`UNIQ--vote-00000069-QINU`"', '"`UNIQ--vote-0000006A-QINU`"', '"`UNIQ--vote-0000006B-QINU`"' (1)
starting dose:
None (37) ·
0.25 mg (1) ·
100 mg IV every 3 months; may increase to 300 mg IV every 3 months (1) ·
225 mg SC monthly, or 675 mg SC every 3 months (quarterly) (1) ·
Migraine: 240 mg SC loading dose, then 120 mg SC monthly. Cluster: 300 mg SC at onset of cluster period, then monthly during cluster. (1)
preparations:
None (37) ·
0.25 mg, 0.5 mg, 1 mg, 2 mg tablets (immediate-release and orally disintegrating); 0.5 mg, 1 mg, 2 mg, 3 mg extended-release tablets; 1 mg/mL oral concentrate (1) ·
100 mg/mL vial for IV infusion (1) ·
120 mg/mL prefilled syringe or autoinjector (1) ·
225 mg/1.5 mL prefilled syringe or autoinjector (1)
fda max:
routes:
onset:
duration:
halflife:
bioavailability:
legal:
Showing below up to 41 results in range #1 to #41.